genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
BioInvent International
Drug Discovery
Pfizer Invests $6M in BioInvent for Myeloid Cell Antibody Partnership
Drug Discovery
Failure of Anticoagulant Prompts BioInvent to Seek $2.2M Cost Cuts
Cancer
BioInvent, CRT, Queen Mary College Establish Anticancer Antibody Discovery Pact
Cancer
BioInvent and ThromboGenics Earn €10M as Roche Progresses Anticancer Agent
Drug Discovery
BioInvent Cans Contract Manufacturing Activities to Focus on Proprietary Drug Development
Drug Discovery
BioInvent and Human Genome Sciences Pool Expertise for mAb Therapeutics Alliance
News
Daiichi and BioInvent Team Up in Antibody Therapeutics Collaboration
News
BIO Exclusive: BioInvent Stays the Course
Bioprocessing
CMOs Hold Their Ground in Troubled Times
Cancer
ThromboGenics and BioInvent Receive $6.5M Fee from Roche under Deal Covering Anticancer mAb
1
2
Page 1 of 2
Scroll Up